These direct effects are linked to liver kinase B1 (LKB1)-mediated activation of AMP-activated protein kinase (AMPK) and suppression of mammalian target of rapamycin (mTOR) signaling and protein synthesis in cancer cells. Here, STK11 is linked to cancer.